RIVER EDGE, N.J., March 23 /PRNewswire-FirstCall/ -- Nephros, Inc. , a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that is has entered into a development agreement with STERIS Corporation .
"Nephros is investigating a range of commercial, industrial and retail opportunities for its DSU technology," said Ernest Elgin, President and CEO of Nephros. "We are pleased to be working with STERIS to leverage our expertise in additional applications. STERIS is a leader in the field of medical device sterilization, and we look forward to developing new products together to enhance patient safety."
About STERIS
About Nephros, Inc.
For more information about Nephros, please visit our website at http://www.nephros.com.
Statements in this news release that are not historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Such statements may be preceded by words such as "may," "plans," "expects," "believes," "hopes," "potential" or similar words. For such statements, Nephros claims the protection of the PSLRA.
CONTACT: Eileen Sukumaran, Eileen@nephros.com, +1-201-343-5202
Web site: http://www.nephros.com/
